Chemosensitization of cancer cells by siRNA using targeted nanogel deliveryReportar como inadecuado


Chemosensitization of cancer cells by siRNA using targeted nanogel delivery


Chemosensitization of cancer cells by siRNA using targeted nanogel delivery - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Background. Chemoresistance is a major obstacle in cancer treatment. Targeted therapies that enhance cancer cell sensitivity to chemotherapeutic agents have the potential to increase drug efficacy while reducing toxic effects on untargeted cells. Targeted cancer therapy by RNA interference RNAi is a relatively new approach that can be used to reversibly silence genes in vivo by selectively targeting genes such as the epidermal growth factor receptor EGFR, which has been shown to increase the sensitivity of cancer cells to taxane chemotherapy. However, delivery represents the main hurdle for the broad development of RNAi therapeutics.Methods. We report here the use of core-shell hydrogel nanoparticles nanogels functionalized with peptides that specially target the EphA2 receptor to deliver small interfering RNAs siRNAs targeting EGFR. Expression of EGFR was determined by immunoblotting, and the effect of decreased EGFR expression on chemosensitization of ovarian cancer cells after siRNA delivery was investigated.Results. Treatment of EphA2 positive Hey cells with siRNA-loaded, peptide-targeted nanogels decreased EGFR expression levels and significantly increased the sensitivity of this cell line to docetaxel P < 0.05. Nanogel treatment of SK-OV-3 cells, which are negative for EphA2 expression, failed to reduce EGFR levels and did not increase docetaxel sensitivity P > 0.05.



School of Biology Faculty Publications -



Autor: Dickerson, Erin B. - Blackburn, William H. - Kapa, Laura B. - Lyon, L. Andrew - McDonald, John F. - -

Fuente: https://smartech.gatech.edu/







Documentos relacionados